Liver International

Liver International is a leading peer-reviewed journal dedicated to the comprehensive study of the liver, its diseases, and related clinical and basic science. Published monthly by Wiley, the journal serves as an essential resource for hepatologists, gastroenterologists, internists, surgeons, and biomedical researchers engaged in hepatic pathophysiology. The journal’s scope encompasses all aspects of hepatology, including viral hepatitis, cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease, alcoholic liver disease, autoimmune and cholestatic liver disorders, liver transplantation, and hepatic fibrosis. It also covers cutting-edge topics such as liver immunology, stem cell biology, and genetic liver diseases. Liver International publishes a diverse range of article types to accommodate the breadth of the field, including original research articles, comprehensive reviews, meta-analyses, editorials, concise rapid communications, and high-impact clinical and translational studies. The journal notably offers an open access publishing option, allowing authors to make their work freely accessible to a global audience. With a 2026 Impact Factor of 6.200, Liver International is ranked in the JCR Q1 quartile, placing it among the top-tier journals in the gastroenterology and hepatology category. This strong citation performance, combined with its rigorous peer review and international editorial board, underscores the journal’s reputation as a premier venue for disseminating high-quality, influential research that advances the understanding and management of liver disease.